DLCL.BO BSE
Dr. Lalchandani Labs Ltd.
1W: -7.1%
1M: -11.6%
3M: -13.1%
YTD: -56.6%
1Y: -52.7%
₹6.89 ($0.07)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$45M
-7.4% ▼
5Y CAGR: -6.1%
Gross Profit
$35M
+108.4% ▲
5Y CAGR: -3.0%
Operating Income
$4M
-66.5% ▼
5Y CAGR: -22.3%
Net Income
$4M
-32.4% ▼
5Y CAGR: -2.5%
EPS (Diluted)
$0.96
-32.9% ▼
5Y CAGR: -2.5%
EBITDA
$11M
+352.3% ▲
5Y CAGR: -3.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $98M | $113M | $50M | $48M | $45M |
| YoY Growth | +60.2% | +15.3% | -55.3% | -4.6% | -7.4% |
| Cost of Revenue | $36M | $30M | $12M | $31M | $10M |
| Gross Profit | $62M | $83M | $38M | $17M | $35M |
| Gross Margin | 63.1% | 73.6% | 75.9% | 34.9% | 78.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5M | $8M | $4M | $6M | $3M |
| Operating Expenses | $44M | $64M | $43M | $6M | $31M |
| Operating Income | $17M | $19M | $15M | $11M | $4M |
| Operating Margin | 17.8% | 16.8% | 30.0% | 22.3% | 8.1% |
| Interest Expense | $2M | $5M | $9M | $4M | $854K |
| Income Before Tax | $14M | $13M | -$16M | $6M | $4M |
| Tax Expense | $4M | $4M | $0 | $0 | -$150K |
| Net Income | $10M | $9M | -$16M | $6M | $4M |
| Net Margin | 10.3% | 8.3% | -31.0% | 12.8% | 9.4% |
| EPS (Diluted) | $2.33 | $2.15 | $-3.61 | $1.43 | $0.96 |
| EBITDA | $21M | $24M | -$171K | $2M | $11M |
| Shares Outstanding | 4M | 4M | 4M | 4M | 4M |